{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:17Z","timestamp":1787020877055,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2013-CoG 614739-A_HERO"],"award-info":[{"award-number":["ERC-2013-CoG 614739-A_HERO"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13071-016-1616-0","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T20:06:13Z","timestamp":1467317173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections"],"prefix":"10.1186","volume":"9","author":[{"given":"Jennifer","family":"Keiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Panic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Adelfio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Scandale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"1616_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1756-3305-5-81","volume":"5","author":"RL Pullan","year":"2012","unstructured":"Pullan RL, Brooker SJ. The global limits and population at risk of soil-transmitted helminth infections in 2010. Parasit Vectors. 2012;5:81.","journal-title":"Parasit Vectors"},{"key":"1616_CR2","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","volume":"386","author":"CJ Murray","year":"2015","unstructured":"Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition. Lancet. 2015;386:2145\u201391.","journal-title":"Lancet"},{"key":"1616_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3855\/jidc.3183","volume":"8","author":"SC Ojha","year":"2014","unstructured":"Ojha SC, Jaide C, Jinawath N, Rotjanapan P, Baral P. Geohelminths: public health significance. J Infect Dev Ctries. 2014;8:5\u201316.","journal-title":"J Infect Dev Ctries"},{"key":"1616_CR4","first-page":"705","volume":"90","author":"World Health Organisation","year":"2015","unstructured":"World Health Organisation. Soil-transmitted helminthiases: number of children treated in 2014. Wkly Epidemiol Rec. 2015;90:705\u201311.","journal-title":"Wkly Epidemiol Rec"},{"key":"1616_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-308X(10)73008-6","volume":"73","author":"J Keiser","year":"2010","unstructured":"Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv Parasitol. 2010;73:197\u2013230.","journal-title":"Adv Parasitol"},{"key":"1616_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-3305-6-42","volume":"6","author":"D Wimmersberger","year":"2013","unstructured":"Wimmersberger D, Tritten L, Keiser J. Development of an in vitro drug sensitivity assay for Trichuris muris first-stage larvae. Parasit Vectors. 2013;6:42.","journal-title":"Parasit Vectors"},{"key":"1616_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","volume":"4","author":"G Panic","year":"2014","unstructured":"Panic G, Duthaler U, Speich B, Keiser J. Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist. 2014;4:185\u2013200.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1616_CR8","doi-asserted-by":"crossref","unstructured":"de Hostos EL, Nguyen T. Anthelmintic drugs: tools and shortcuts for the long road from discovery to product. In: Parasitic Helminths: Wiley-VCH Verlag GmbH & Co. KGaA; 2012: 217\u2013232.","DOI":"10.1002\/9783527652969.ch13"},{"key":"1616_CR9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.chembiol.2011.07.011","volume":"18","author":"Y Cho","year":"2011","unstructured":"Cho Y, Vermeire JJ, Merkel JS, Leng L, Du X, Bucala R, et al.\u00a0Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors. Chem Biol. 2011;18:1089\u2013101.","journal-title":"Chem Biol"},{"key":"1616_CR10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/pim.12037","volume":"35","author":"RA Paveley","year":"2013","unstructured":"Paveley RA, Bickle QD. Automated imaging and other developments in whole-organism anthelmintic screening. Parasite Immunol. 2013;35:302\u201313.","journal-title":"Parasite Immunol"},{"key":"1616_CR11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","volume":"10","author":"DC Swinney","year":"2011","unstructured":"Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov. 2011;10:507\u201319.","journal-title":"Nat Rev Drug Discov"},{"key":"1616_CR12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pt.2015.08.004","volume":"31","author":"J Keiser","year":"2015","unstructured":"Keiser J. Is Caenorhabditis elegans the magic bullet for anthelminthic drug discovery? Trends Parasitol. 2015;31:455\u20136.","journal-title":"Trends Parasitol"},{"key":"1616_CR13","doi-asserted-by":"crossref","first-page":"e0003962","DOI":"10.1371\/journal.pntd.0003962","volume":"9","author":"G Panic","year":"2015","unstructured":"Panic G, Vargas M, Scandale I, Keiser J. Activity profile of an FDA-approved compound library against Schistosoma mansoni. PLoS Negl Trop Dis. 2015;9:e0003962.","journal-title":"PLoS Negl Trop Dis"},{"key":"1616_CR14","doi-asserted-by":"crossref","first-page":"e1762","DOI":"10.1371\/journal.pntd.0001762","volume":"6","author":"RA Paveley","year":"2012","unstructured":"Paveley RA, Mansour NR, Hallyburton I, Bleicher LS, Benn AE, Mikic I, et al. Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases. PLoS Negl Trop Dis. 2012;6:e1762.","journal-title":"PLoS Negl Trop Dis"},{"key":"1616_CR15","doi-asserted-by":"crossref","first-page":"e1457","DOI":"10.1371\/journal.pntd.0001457","volume":"5","author":"L Tritten","year":"2011","unstructured":"Tritten L, Silbereisen A, Keiser J. In vitro and in vivo efficacy of monepantel (AAD 1566) against laboratory models of human intestinal nematode infections. PLoS Negl Trop Dis. 2011;5:e1457.","journal-title":"PLoS Negl Trop Dis"},{"key":"1616_CR16","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1371\/journal.pntd.0002610","volume":"8","author":"K Ingram-Sieber","year":"2014","unstructured":"Ingram-Sieber K, Cowan N, Panic G, Vargas M, Mansour NR, Bickle QD, et al. Orally active antischistosomal early leads identified from the open access malaria box. PLoS Negl Trop Dis. 2014;8:e2610.","journal-title":"PLoS Negl Trop Dis"},{"key":"1616_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/pim.12057","volume":"36","author":"NL Harris","year":"2014","unstructured":"Harris NL, Pleass R, Behnke JM. Understanding the role of antibodies in murine infections with Heligmosomoides (polygyrus) bakeri: 35\u00a0years ago, now and 35\u00a0years ahead. Parasite Immunol. 2014;36:115\u201324.","journal-title":"Parasite Immunol"},{"key":"1616_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.aquatox.2012.12.024","volume":"130\u2013131","author":"CC Chang","year":"2013","unstructured":"Chang CC, Rahmawaty A, Chang ZW. Molecular and immunological responses of the giant freshwater prawn, Macrobrachium rosenbergii, to the organophosphorus insecticide, trichlorfon. Aquat Toxicol. 2013;130\u2013131:18\u201326.","journal-title":"Aquat Toxicol"},{"key":"1616_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1517\/14656566.5.2.263","volume":"5","author":"J Utzinger","year":"2004","unstructured":"Utzinger J, Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother. 2004;5:263\u201385.","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 1","key":"1616_CR20","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1007\/s00436-011-2410-8","volume":"109","author":"C Fiel","year":"2011","unstructured":"Fiel C, Guzman M, Steffan P, Rodriguez E, Prieto O, Bhushan C. The efficacy of trichlorphon and naphthalophos against multiple anthelmintic-resistant nematodes of naturally infected sheep in Argentina. Parasitol Res. 2011;109 Suppl 1:S139\u201348.","journal-title":"Parasitol Res"},{"key":"1616_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1527-3458.1999.tb00083.x","volume":"5","author":"LS Schneider","year":"1999","unstructured":"Schneider LS, Giacobini E. Metrifonate. A cholinesterase inhibitor for Alzheimer\u2019s disease therapy. CNS Drug Rev. 1999;5:13\u201326.","journal-title":"CNS Drug Rev"},{"key":"1616_CR22","first-page":"Cd003155","volume":"2","author":"JM Lopez-Arrieta","year":"2006","unstructured":"Lopez-Arrieta JM, Schneider L. Metrifonate for Alzheimer's disease. Cochrane Database Syst Rev. 2006;2:Cd003155.","journal-title":"Cochrane Database Syst Rev"},{"key":"1616_CR23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0022149X1400039X","volume":"89","author":"RJ Martin","year":"2015","unstructured":"Martin RJ, Puttachary S, Buxton SK, Verma S, Robertson AP. The Conqueror Worm: recent advances with cholinergic anthelmintics and techniques excite research for better therapeutic drugs. J Helminthol. 2015;89:387\u201397.","journal-title":"J Helminthol"},{"key":"1616_CR24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nature06722","volume":"452","author":"R Kaminsky","year":"2008","unstructured":"Kaminsky R, Ducray P, Jung M, Clover R, Rufener L, Bouvier J, et al. A new class of anthelmintics effective against drug-resistant nematodes. Nature. 2008;452:176\u201380.","journal-title":"Nature"},{"key":"1616_CR25","doi-asserted-by":"crossref","first-page":"e1000380","DOI":"10.1371\/journal.ppat.1000380","volume":"5","author":"L Rufener","year":"2009","unstructured":"Rufener L, Maser P, Roditi I, Kaminsky R. Haemonchus contortus acetylcholine receptors of the DEG-3 subfamily and their role in sensitivity to monepantel. PLoS Pathog. 2009;5:e1000380.","journal-title":"PLoS Pathog"},{"key":"1616_CR26","doi-asserted-by":"crossref","first-page":"e1003870","DOI":"10.1371\/journal.ppat.1003870","volume":"10","author":"SK Buxton","year":"2014","unstructured":"Buxton SK, Charvet CL, Neveu C, Cabaret J, Cortet J, Peineau N, et al. Investigation of acetylcholine receptor diversity in a nematode parasite leads to characterization of tribendimidine- and derquantel-sensitive nAChRs. PLoS Pathog. 2014;10:e1003870.","journal-title":"PLoS Pathog"},{"key":"1616_CR27","first-page":"64","volume":"19","author":"T Harinasuta","year":"1975","unstructured":"Harinasuta T, Bunnag D. Clinical field trial of bitoscanate in Necator americanus infection, South Thailand. Prog Drug Res. 1975;19:64\u20139.","journal-title":"Prog Drug Res"},{"key":"1616_CR28","first-page":"96","volume":"19","author":"MR Samuel","year":"1975","unstructured":"Samuel MR. Clinical experience with bitoscanate. Prog Drug Res. 1975;19:96\u2013107.","journal-title":"Prog Drug Res"},{"key":"1616_CR29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1039\/B615424G","volume":"4","author":"MS Pedras","year":"2007","unstructured":"Pedras MS, Zheng QA, Gadagi RS. The first naturally occurring aromatic isothiocyanates, rapalexins A and B, are cruciferous phytoalexins. Chem Commun (Camb). 2007;4:368\u201370.","journal-title":"Chem Commun (Camb)"},{"key":"1616_CR30","doi-asserted-by":"crossref","unstructured":"Biagi F. Experience with bitoscanate in hookworm disease and trichuriasis in Mexico. Prog Drug Res. 1975: 23\u201327","DOI":"10.1007\/978-3-0348-7090-0_4"},{"key":"1616_CR31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4269\/ajtmh.1986.35.945","volume":"35","author":"TA Shapiro","year":"1986","unstructured":"Shapiro TA, Were JB, Talalay P, Bueding E, Rocco L, Danso K, et al. Clinical evaluation of amoscanate in healthy male volunteers. Am J Trop Med Hyg. 1986;35:945\u201353.","journal-title":"Am J Trop Med Hyg"},{"key":"1616_CR32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4269\/ajtmh.1977.26.636","volume":"26","author":"JC Doshi","year":"1977","unstructured":"Doshi JC, Vaidya AB, Sen HG, Mankodi NA, Nair CN, Grewal RS. Clinical trials of a new anthelmintic, 4-isothiocyanato-4\u2032-nitrodiphenylamine (C.9333-Go\/CGP 4540), for the cure of hookworm infection. Am J Trop Med Hyg. 1977;26:636\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1616_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2460\/ajvr.1991.52.04.574","volume":"52","author":"TM Craig","year":"1991","unstructured":"Craig TM, Mercer SH, Wade CG, Lynn RC. Efficacy of nitroscanate against naturally acquired infection with Ancylostoma caninum, Dipylidium caninum, and Trichuris vulpis in dogs. Am J Vet Res. 1991;52:574\u20135.","journal-title":"Am J Vet Res"},{"key":"1616_CR34","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1038\/srep22263","volume":"6","author":"D Nowicki","year":"2016","unstructured":"Nowicki D, Rodzik O, Herman-Antosiewicz A, Szalewska-Palasz A. Isothiocyanates as effective agents against enterohemorrhagic Escherichia coli: insight to the mode of action. Sci Rep. 2016;6:22263.","journal-title":"Sci Rep"},{"key":"1616_CR35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/aps.2009.50","volume":"30","author":"X Wu","year":"2009","unstructured":"Wu X, Zhou QH, Xu K. Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin. 2009;30:501\u201312.","journal-title":"Acta Pharmacol Sin"},{"key":"1616_CR36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/371707a0","volume":"371","author":"DF Cully","year":"1994","unstructured":"Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LH, Schaeffer JM, Arena JP. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature. 1994;371:707\u201311.","journal-title":"Nature"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1616-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T21:16:06Z","timestamp":1718658966000},"score":1,"resource":{"primary":{"URL":"http:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-016-1616-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1616-0","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]},"article-number":"376"}}